These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6817037)

  • 1. Comparative ultrastructure of a mucoid strain of Pseudomonas aeruginosa isolated from cystic fibrosis patient and its spontaneous non-mucoid mutant.
    Dunne WM; Buckmire FL; Kushnaryov VM
    Microbios; 1982; 34(137-38):197-212. PubMed ID: 6817037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of nutrient media on the characteristics of the exopolysaccharide produced by three mucoid Pseudomonas aeruginosa strains.
    Buckmire FL
    Microbios; 1984; 41(163):49-63. PubMed ID: 6441885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucoid Pseudomonas in cystic fibrosis.
    Pritt B; O'Brien L; Winn W
    Am J Clin Pathol; 2007 Jul; 128(1):32-4. PubMed ID: 17580270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological markers for Pseudomonas aeruginosa. 6. Relationship between concomitant non-mucoid and mucoid strains from the respiratory tract in cystic fibrosis.
    Bergan T; Hoiby N
    Acta Pathol Microbiol Scand Suppl; 1975 Dec; 83(6):553-60. PubMed ID: 812335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alginate lyase enhances antibiotic killing of mucoid Pseudomonas aeruginosa in biofilms.
    Alkawash MA; Soothill JS; Schiller NL
    APMIS; 2006 Feb; 114(2):131-8. PubMed ID: 16519750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence ability of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis to two different epithelial cell lines.
    Vranes J; Tjesić-Drinković D; Zulj I; Kruzić V; Turković B; Marić S
    Coll Antropol; 2004 Dec; 28(2):675-80. PubMed ID: 15666599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyagglutinable Pseudomonas aeruginosa from cystic fibrosis patients. A survey.
    Ojeniyi B
    APMIS Suppl; 1994; 46():1-44. PubMed ID: 7811529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of mucoid microcolonies by Pseudomonas aeruginosa within infected lungs in cystic fibrosis.
    Lam J; Chan R; Lam K; Costerton JW
    Infect Immun; 1980 May; 28(2):546-56. PubMed ID: 6772562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale for development of immunotherapies that target mucoid Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Pier GB
    Behring Inst Mitt; 1997 Feb; (98):350-60. PubMed ID: 9382760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electron microscopy of malachite green--glutaraldehyde fixed bacteria.
    Kushnaryov VM; Dunne WM; Buckmire FL
    Stain Technol; 1979 Nov; 54(6):331-5. PubMed ID: 94953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody response of rabbits and cystic fibrosis patients to an alginate-specific outer membrane protein of a mucoid strain of Pseudomonas aeruginosa.
    Rehm BH; Grabert E; Hein J; Winkler UK
    Microb Pathog; 1994 Jan; 16(1):43-51. PubMed ID: 8057826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of divalent cations on the synthesis of alginic acid-like exopolysaccharide from mucoid Pseudomonas aeruginosa.
    Dunne WM; Buckmire FL
    Microbios; 1985; 43(174-175):193-216. PubMed ID: 3937956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular neuraminidase production by a strain of Pseudomonas aeruginosa isolated from cystic fibrosis.
    Leprat R; Michel-Briand Y
    Ann Microbiol (Paris); 1980; 131B(3):209-22. PubMed ID: 6781392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of characterised Pseudomonas aeruginosa exopolysaccharides on adherence to human tracheal cells.
    Marty N; Pasquier C; Dournes JL; Chemin K; Chavagnat F; Guinand M; Chabanon G; Pipy B; Montrozier H
    J Med Microbiol; 1998 Feb; 47(2):129-34. PubMed ID: 9879955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients.
    Meluleni GJ; Grout M; Evans DJ; Pier GB
    J Immunol; 1995 Aug; 155(4):2029-38. PubMed ID: 7636254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic differences among clinically isolated mucoid Pseudomonas aeruginosa strains.
    Pugashetti BK; Metzger HM; Vadas L; Feingold DS
    J Clin Microbiol; 1982 Oct; 16(4):686-91. PubMed ID: 6818245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the outer membrane protein and lipopolysaccharide profiles of mucoid and nonmucoid Pseudomonas aeruginosa.
    Kelly NM; MacDonald MH; Martin N; Nicas T; Hancock RE
    J Clin Microbiol; 1990 Sep; 28(9):2017-21. PubMed ID: 2121789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteome analysis reveals adaptation of Pseudomonas aeruginosa to the cystic fibrosis lung environment.
    Sriramulu DD; Nimtz M; Romling U
    Proteomics; 2005 Sep; 5(14):3712-21. PubMed ID: 16097035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MutS deficiency and activity of the error-prone DNA polymerase IV are crucial for determining mucA as the main target for mucoid conversion in Pseudomonas aeruginosa.
    Moyano AJ; Luján AM; Argaraña CE; Smania AM
    Mol Microbiol; 2007 Apr; 64(2):547-59. PubMed ID: 17493134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.